Video Library

Multiple myeloma is the most common cancer of the bone marrow. This presentation discusses transplant options and drug therapies for treating myeloma. It also reviews options for maintenance therapy and responding to relapses.

CAR T-cell therapy is new treatment option for patients with certain types of non-Hodgkin lymphoma, acute lymphoblastic leukemia and multiple myeloma who relapsed or did not respond to other treatments. This presentation discusses who is eligible to receive CAR T-cell therapy, what the procedure entails and potential side effects.

The practice of mindfulness has proven benefits for transplant patients. It reduces stress and improves psychological health and well-being. This presentation describes several mindfulness practices and offers tips on how to integrate them into your daily life.

There are many kinds of insurance plans and coverages available in the United States. This presentation describes different plans in both the private market and government sector to guide patients through the maze of options. It also describes how different plans may complement one another and provide fuller coverage than any single plan on its own.

eturning to work after transplant poses many challenges. Several Federal and state laws provide workers who are struggling with a serious illness, and in some cases, their family members, protection against job discrimination, guaranteed time off work to recover or care for a loved one, job security while off work, and/or money to help replace lost wages.

Occupational therapists can help transplant recipients manage their fatigue, and redesign their lifestyle to improve quality of life, while recovering transplant and side effects such as graft-versus-host disease (GVHD).

Puntos clave: 19:17 Tener la enfermedad de injerto contra huésped es un factor de riesgo adicional de COVID-19. 23:31 Los tratamientos para los casos leves se manejan mejor en casa

It is now my pleasure to introduce your host, Susan Stewart. Susan Stewart ( 00:00:05): Introductions Thank you very much, and welcome to the COVID-19 Winter Update: What Transplant Recipients

Insights and lessons learned from an inspiring survivor’s transplant journey.

Learn about medical complications that can develop months or years after an allogeneic transplant. Learn how you can minimize the risk of developing problems and get appropriate treatment if a complication occurs.

Chronic graft-versus-host disease is a common complication after a transplant using donor cells (allogeneic transplant). Early detection and treatment are critical to successful management of the disease. Side effects from drugs used to treat chronic GVHD can increase the risk of health problems later in life.

A panel of pediatric transplant experts answer patient questions about medical, emotional, social and learning issues children and young adults may face after transplant.